{"id":"https://openalex.org/W178792507","doi":null,"title":"Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study.","display_name":"Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study.","publication_year":1991,"publication_date":"1991-05-01","ids":{"openalex":"https://openalex.org/W178792507","mag":"178792507","pmid":"https://pubmed.ncbi.nlm.nih.gov/2070654"},"language":"en","primary_location":{"id":"pmid:2070654","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2070654","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"T D Griffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T D Griffin","raw_affiliation_strings":["University of Pennsylvania, Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034662559","display_name":"Emma Scott","orcid":"https://orcid.org/0000-0002-5358-5132","observed_orcids":["https://orcid.org/0000-0002-5358-5132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E J Van Scott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6261,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.80585859,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"47","issue":"5","first_page":"325","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11868","display_name":"Cancer and Skin Lesions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/actinic-keratosis","display_name":"actinic keratosis","score":0.828000009059906},{"id":"https://openalex.org/keywords/pyruvate","display_name":"pyruvate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9919999837875366},{"id":"https://openalex.org/keywords/alpha-hydroxy-acids","display_name":"\u03b1-hydroxy acids","score":0.8519999980926514},{"id":"https://openalex.org/keywords/topical-chemotherapy","display_name":"topical chemotherapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.7670000195503235},{"id":"https://openalex.org/keywords/histopathological-response","display_name":"histopathological response","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2910086692","wikidata":"https://www.wikidata.org/wiki/Q422225","display_name":"Actinic keratoses","level":3,"score":0.8904640674591064},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8886828422546387},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.8481847643852234},{"id":"https://openalex.org/C2777179333","wikidata":"https://www.wikidata.org/wiki/Q213580","display_name":"Pyruvic acid","level":2,"score":0.736103355884552},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6353105902671814},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.5991365909576416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3099377751350403},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17612901329994202},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.04874986410140991}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004890","descriptor_name":"Erythema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007642","descriptor_name":"Keratosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007642","descriptor_name":"Keratosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011773","descriptor_name":"Pyruvates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011773","descriptor_name":"Pyruvates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013472","descriptor_name":"Sunlight","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019289","descriptor_name":"Pyruvic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2070654","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2070654","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial"},{"id":"mag:178792507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2070654","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2409747076","https://openalex.org/W2024034796","https://openalex.org/W2409422374","https://openalex.org/W3019029760","https://openalex.org/W4223966493","https://openalex.org/W4868025","https://openalex.org/W2401868130","https://openalex.org/W1862013801","https://openalex.org/W1932200564","https://openalex.org/W2403707608"],"abstract_inverted_index":{"Twelve":[0],"patients":[1,19],"with":[2,8,22,98],"multiple":[3],"actinic":[4,77],"keratoses":[5],"were":[6,20,47],"treated":[7,21],"either":[9],"5-fluorouracil":[10,25,68,85,99],"and":[11,42,69,88],"pyruvic":[12,15,70],"acid":[13,16,71],"or":[14],"alone.":[17,100],"Three":[18],"5":[23],"percent":[24],"cream":[26],"for":[27,32,76],"one":[28,41],"to":[29,36,56,84],"three":[30],"weeks":[31,58],"comparison.":[33],"Exposure":[34],"time":[35,83],"alpha-hydroxy":[37],"acids":[38],"varied":[39],"between":[40],"ten":[43],"minutes.":[44],"Biopsy":[45],"specimens":[46],"taken":[48],"at":[49],"times":[50],"varying":[51],"from":[52],"immediately":[53],"after":[54,59],"treatment":[55,75,91,97],"eight":[57],"treatment.":[60],"The":[61],"results":[62],"show":[63],"that":[64],"the":[65,81],"combination":[66],"of":[67],"is":[72,86,92],"an":[73],"effective":[74],"keratoses.":[78],"In":[79],"addition,":[80],"exposure":[82],"decreased":[87],"therefore":[89],"this":[90],"better":[93],"tolerated":[94],"than":[95],"prolonged":[96]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
